Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$161.01 - $317.85 $2.17 Million - $4.28 Million
-13,467 Reduced 26.81%
36,755 $11.6 Million
Q3 2023

Nov 15, 2023

BUY
$164.66 - $218.08 $1.07 Million - $1.42 Million
6,516 Added 14.91%
50,222 $8.49 Million
Q2 2023

Aug 11, 2023

SELL
$176.32 - $240.22 $605,835 - $825,395
-3,436 Reduced 7.29%
43,706 $9.48 Million
Q1 2023

May 15, 2023

BUY
$161.33 - $204.36 $329,597 - $417,507
2,043 Added 4.33%
49,185 $8.93 Million
Q4 2022

Aug 11, 2023

BUY
$191.53 - $236.82 $420,982 - $520,530
2,198 Added 4.89%
47,142 $9.26 Million
Q4 2022

Feb 13, 2023

BUY
$191.53 - $236.82 $420,982 - $520,530
2,198 Added 4.89%
47,142 $9.26 Million
Q3 2022

Aug 11, 2023

BUY
$123.79 - $277.42 $1.6 Million - $3.59 Million
12,938 Added 40.42%
44,944 $10.1 Million
Q3 2022

Nov 03, 2022

BUY
$123.79 - $277.42 $1.6 Million - $3.59 Million
12,938 Added 40.42%
44,944 $10.1 Million
Q2 2022

Aug 11, 2023

BUY
$93.97 - $143.33 $130,806 - $199,515
1,392 Added 4.55%
32,006 $4.05 Million
Q2 2022

Aug 15, 2022

BUY
$93.97 - $143.33 $130,806 - $199,515
1,392 Added 4.55%
32,006 $4.02 Million
Q1 2022

Aug 11, 2023

SELL
$98.9 - $132.37 $1.84 Million - $2.46 Million
-18,571 Reduced 37.76%
30,614 $3.88 Million
Q1 2022

May 20, 2022

BUY
$98.9 - $132.37 $1.9 Million - $2.55 Million
19,251 Added 169.42%
30,614 $3.8 Million
Q4 2021

Feb 16, 2022

SELL
$110.64 - $159.4 $12,944 - $18,649
-117 Reduced 1.02%
11,363 $1.48 Million
Q3 2021

Nov 12, 2021

SELL
$101.2 - $125.87 $118,808 - $147,771
-1,174 Reduced 9.28%
11,480 $1.4 Million
Q2 2021

Aug 12, 2021

BUY
$107.45 - $135.95 $374,463 - $473,785
3,485 Added 38.01%
12,654 $1.44 Million
Q1 2021

May 03, 2021

SELL
$95.46 - $133.08 $51,834 - $72,262
-543 Reduced 5.59%
9,169 $1.1 Million
Q4 2020

Feb 12, 2021

BUY
$75.23 - $109.23 $21,139 - $30,693
281 Added 2.98%
9,712 $987,000
Q2 2020

Aug 10, 2020

BUY
$62.14 - $117.21 $166,597 - $314,240
2,681 Added 39.72%
9,431 $1 Million
Q1 2020

May 15, 2020

BUY
$60.41 - $115.92 $407,767 - $782,460
6,750 New
6,750 $486,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.